effects of stopping glp 1 November Blog Why do people who stop
Description
A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by 23 to 44%, depending which medication they were on.
The framework prioritised semaglutide and tirzepatide as first-line treatments, based on evidence of 15% weight loss and benefits in complications such as cardiovascular disease and sleep apnoea

Achieve sustainable weight loss with GLP-1 therapy at DrWell
Chandrasekhar et al
Compare MeAgain vs MacroFactor for GLP-1 food tracking

Explore the link between GLP-1 agonists and fatigue, understanding why some experience this side effect.
